🇺🇸 FDA
Patent

US 10370659

Compounds and methods for increasing antisense activity

granted A61KA61K31/7125

Quick answer

US patent 10370659 (Compounds and methods for increasing antisense activity) held by Ionis Pharmaceuticals, Inc. expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/7125